Malignant neoplasms following bone marrow transplantation

Blood

Volumn 87, Issue 9, 1996, Pages 3633-3639

  Bhatia, Smita ^b   Ramsay, Norma K C ^b   Steinbuch, Michael ^b   Dusenbery, Kathryn E ^b   Shapiro, Ralph S ^b   Weisdorf, Daniel J ^b   Robison, Leslie L ^b   Miller, Jeffrey S ^b   Neglia, Joseph P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CHILD; DISEASE ASSOCIATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK ASSESSMENT; T LYMPHOCYTE;

EID: 0030000397     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3633.bloodjournal8793633     Document Type: Article

References (39)

1. Ramsay NKC: Bone marrow transplantation in pediatric oncology, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 2). Philadelphia, PA, Lippincott, 1993, p 315
2. Barrett J, McCarthy D: Bone marrow transplantation for genetic disorders [review]. Blood Rev 4:116, 1991
3. Bortin MM, Rimm AA: Increasing utilization of bone marrow transplantation. Transplantation 48:453, 1989
4. Travis LB, Curtis RE, Glimelius B, Holowaty E, Van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P, Tucker M, Fraumeni JF, Boice JD: Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 85:1932, 1993
5. Boivin JF, Hutchison GB, Zauber AG: Incidence of second cancers in patients treated for Hodgkin's disease. J Natl Cancer Inst 87:732, 1995
6. Greene MH, Young TI, Clark WH, Jr: Malignant melanoma in renal-transplant recipients. Lancet i:1196, 1981
7. Deeg HJ, Prentice R, Fritz TE, Sale GE, Lombard LS, Thomas ED, Storb R: Increased incidence of malignant tumors in dogs after total body irradiation and marrow transplantation. Int J Radiat Oncol Biol Phys 9:1505, 1983
8. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb R, Thomas ED: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:784, 1989
9. Deeg HJ, Witherspoon RP: Risk factors for the development of secondary malignancies after marrow transplantation. Hematol Oncol Clin North Am 7:417, 1993
10. Kolb HJ, Guenther W, Duell T, Socie G, Schaeffer E, Holler E, Schemm M, Horowitz MM, Gale RP, Fliender TM: Cancer after bone marrow transplantation. Bone Marrow Transplant 10:135, 1992 (suppl 1)
11. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, Mcglave P, Filipovich AH: Epstein Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234, 1988
12. Witherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM: Cumulative incidence of second malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone. Blood 79:289, 1992 (letter)
13. Deeg HJ, Sanders J, Martin P, Fefer A, Neiman P, Singer J, Storb R, Thomas ED: Secondary malignancies after marrow transplantation. Exp Hematol 12:660, 1984
14. Miller BA, Reis LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, Edwards BK (eds): SEER Cancer Statistics Review: 1973-1990. National Cancer Institute. NIH Pub. No. 93-2789, 1993
15. Vandenbroucke JP: A shortcut method for calculating the 95 percent confidence interval of the standardized mortality ratio. Am J Epidemiol 115:303, 1982
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457, 1958
17. Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ: Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy. Blood 83:3780, 1994
18. Neglia JP, Meadows AT, Oration LL, Kin TH, Newton WA, Ruymann FB, Sather HN, Hammond GD: Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325:1330, 1991
19. Greene MH, Wilson J: Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. National Cancer Institute monograph 68. Washington, DC: Government Printing Office, 1985, p 191
20. Hawkins MM, Draper GJ, Kingston JE: Incidence of second primary tumors among childhood cancer survivors. Br J Cancer 56:339, 1987
21. Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H: Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 12:2187, 1994
22. Iori AP, Arcese W, Pinto RM, Favre C, Macchia P: Malignant fibrous Histiocytoma secondary to allogeneic bone marrow transplantation. Bone Marrow Transplant 14.492, 1994
23. Uderzo C, van Lint MT, Rovelli A, Weber G, Castellani MR, Bacigalupo A, Masera N, Cohen A: Papillary thyroid carcinoma after total body irradiation. Arch Dis Child 71:256, 1994
24. Ho M, Miller G, Atchinson RW, Breinig MK, Dummer JS, Andiman W, Starzl TE, Eastman R, Griffith BP: Epstein-Barr virus infections and DNA hybridization studies in post-transplantation lymphoma and lymphoproliferative lesions: Role of primary infection. J Infect Dis 152:876, 1985
25. Andiman WA, Gradoville L, Heston L, Neydorff R, Savage ME, Kitchingman G, Shedd D, Miller G: Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative disease. J Infect Dis 148:967, 1983
26. Starzl TE, Naleskin MA, Porter KA, Ho M, Iwatsaki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW, Hardesty RL, Atchinson RW, Jaffe R, Behnson HT: Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583, 1984
27. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS: Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41:4253, 1981
28. Maralleau JP, Brice P, Morel P, Gisselbrecht C: Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphoma. J Clin Oncol 11:590, 1993
29. Stone RM: Myelodysplastic syndrome after autologous transplantation for lymphoma: The price of progress? Blood 83:3437, 1994
30. Chan T, Juneja S, Wolf M, Januszewicz E, Cooper I: Secondary myelodysplastic syndrome following bone marrow transplantation: Report of two cases. Bone Marrow Transplant 13:145, 1994
31. Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS: Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 12:2535, 1994
32. Anderson JR, Vose J, Kessinger A: Myelodysplastic syndrome after autologous transplant for lymphoma Blood 84:3988, 1994 (letter)
33. Blaney DW, Longo DL, Young RC, Greene MH, Hubbard SM, Postal MG, Duffey PL, DeVita VT: Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 16:710, 1987
34. Hancock SL, Tucker MA, Hoppe RT: Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25, 1993
35. Abrahamsen JF, Anderson A, Hannisdal E, Nome O, Abrahamsen AF, Kvoloy S, Host H: Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time and age. J Clin Oncol 11:255, 1993
36. Socie G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E: Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 78:277, 1991
37. Lishner M, Patterson B, Kandel R, Fyles G, Curtis JE, Meharchand J, Minden MD, Messner HA: Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 65:473, 1990
38. Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Veer-Korthof EV, Gluckman E: Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 329:1152, 1993
39. Socie G, Henry-Amar M, Devergie A, Wibault P, Neiger M, Cosset JM, Gluckman E: Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia. Leuk Lymph 7:419, 1992